Sonoma Pharmaceuticals, Inc.
SNOANASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $4.42M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.85$4.25
- Volume (live)
- -
- Avg. volume (3M)
- 47.27K
Sonoma Pharmaceuticals (SNOA) Stock Price & Financial Analysis
Sonoma Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.12 - $1.23 |
|---|---|
| 52-Week High | $4.25 |
| 52-Week Low | $0.85 |
| Open | $1.23 |
| Volume (last close) | 56.86K |
| Average Volume (3M) | 47.27K |
| Revenue (TTM) | 21.92M |
|---|---|
| Net Income (TTM) | -2.26M |
| Free Cash Flow (TTM) | -2.65M |
| EPS (TTM) | −$1.01 |
| Profit Margin | -10.33% |
| Operating Margin | -6.41% |
| Return on Equity (ROE) | -34.33% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.42M |
|---|---|
| Shares Outstanding | 3.85M |
| Price to Sales (P/S) | 0.20 |
| Price to Book (P/B) | 0.67 |
| EV/EBITDA | 0.26 |
| 50-Day MA | $1.28 |
|---|---|
| 200-Day MA | $1.85 |
| 1-Year Change | −69.97% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Sonoma Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Sonoma Pharmaceuticals (SNOA) has a market capitalization of $4.42M. The stock trades at 0.2× sales. Over the trailing twelve months it lost $2.26M on revenue of $21.92M and burned $2.65M of free cash flow. Revenue grew 47.0% year over year.
As of its latest reported balance sheet, it holds $5.34M in cash and securities against $579.00K of debt, a net cash position of $4.76M.
Sonoma Pharmaceuticals does not currently pay a dividend.
The share price is down 70.0% over the past year. At $1.12 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.85 to $4.25, below its 200-day moving average of $1.85.
Frequently Asked Questions About Sonoma Pharmaceuticals
What is the current stock price for SNOA?
As of the Oct 16, 2026 close, SNOA stock trades at $1.12. The 52-week range is $0.85–$4.25, with a day range of $1.12–$1.23.
What is the P/E ratio for SNOA?
The P/E ratio (Price-to-Earnings) for SNOA is shown in the Key Statistics section. This valuation metric helps compare Sonoma Pharmaceuticals, Inc. to industry peers.
Does SNOA pay dividends?
Sonoma Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SNOA?
Analyst ratings and recommendations for SNOA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SNOA?
As of the Oct 16, 2026 close, Sonoma Pharmaceuticals's market capitalization is $4.3M, classifying it as a micro-cap company. Sonoma Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.